These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38649554)

  • 21. Impacts of COVID-19 on sexual risk behaviors, safe injection practices, and access to HIV services among key populations in Zambia: Findings from a rapid qualitative formative assessment.
    Parmley LE; Nkumbula T; Chilukutu L; Chelu L; Mulemfwe C; Hanunka B; Mwale J; Neal J; Handema R; Kasonde P; Mutale K; Sakala HM; Lahuerta M
    PLoS One; 2023; 18(8):e0289007. PubMed ID: 37527283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spore forming bacteria infections and people who inject drugs: Implications for harm reduction.
    Dunleavy K; Munro A; Roy K; Hutchinson S; Palmateer N; Knox T; Goldberg D; Hope V; Campbell J; Hamilton E; Liddell D; Penrice G; Taylor A
    Int J Drug Policy; 2018 Mar; 53():45-54. PubMed ID: 29281807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016.
    Dasgupta S; Broz D; Tanner M; Patel M; Halleck B; Peters PJ; Weidle PJ; O'Donnell J; Amlung J; McAlister C; Chapman E; Bailey A; Burnett J; Duwve J
    AIDS Behav; 2019 Dec; 23(12):3257-3266. PubMed ID: 31313095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
    Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
    J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran.
    Nakhaeizadeh M; Abdolahinia Z; Sharifi H; Mirzazadeh A; Haghdoost AA; Shokoohi M; Baral S; Karamouzian M; Shahesmaeili A
    Harm Reduct J; 2020 Jul; 17(1):50. PubMed ID: 32698875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.
    Doshi S; Kingston H; Tseng AS; Chohan BH; Sambai B; Guthrie BL; Monroe-Wise A; Mbogo LW; Masyuko S; Tram KH; Sinkele W; Macharia P; Bukusi D; Herbeck JT; Farquhar C
    Harm Reduct J; 2023 Feb; 20(1):21. PubMed ID: 36823596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
    Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study.
    Doyle CM; Cox J; Milwid RM; Bitera R; Delaunay CL; Alary M; Lambert G; Tremblay C; Mishra S; Maheu-Giroux M
    J Int AIDS Soc; 2022 Sep; 25(9):e25994. PubMed ID: 36050916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of COVID-19 vaccination among people who inject drugs.
    Iversen J; Wand H; Kemp R; Bevan J; Briggs M; Patten K; Heard S; Maher L
    Harm Reduct J; 2022 Jun; 19(1):59. PubMed ID: 35655217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of HIV among people who inject drugs after the HIV-outbreak in Athens, Greece: Evidence for a 'slow burn' outbreak.
    Kostaki EG; Roussos S; Kefala AM; Limnaios S; Psichogiou M; Papachristou E; Nikolopoulos G; Flountzi E; Friedman SR; Lagiou P; Hatzakis A; Sypsa V; Magiorkinis G; Beloukas A; Paraskevis D
    Infect Genet Evol; 2024 Jul; 121():105597. PubMed ID: 38663466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel.
    Katchman E; Ben-Ami R; Savyon M; Chemtob D; Avidor B; Wasserman A; Zeldis I; Girshengorn S; Amitai Z; Sheffer R; Turner D
    Clin Microbiol Infect; 2017 May; 23(5):336.e5-336.e8. PubMed ID: 27876594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
    Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
    Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.
    Ganapathi L; McFall AM; Srikrishnan AK; Kumar MS; Anand S; Lucas GM; Mehta SH; Harris SK; Solomon SS
    J Int AIDS Soc; 2019 May; 22(5):e25287. PubMed ID: 31116005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.
    Ragonnet-Cronin M; Jackson C; Bradley-Stewart A; Aitken C; McAuley A; Palmateer N; Gunson R; Goldberg D; Milosevic C; Leigh Brown AJ
    J Infect Dis; 2018 May; 217(12):1875-1882. PubMed ID: 29546333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk.
    Yeager S; Abramovitz D; Harvey-Vera AY; Vera CF; Algarin AB; Smith LR; Rangel G; Artamonova I; Patterson TL; Bazzi AR; Brugman EL; Strathdee SA
    BMC Public Health; 2022 Apr; 22(1):842. PubMed ID: 35473678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.
    Furukawa NW; Weimer M; Willenburg KS; Kilkenny ME; Atkins AD; Paul McClung R; Hansen Z; Napier K; Handanagic S; Carnes NA; Kemp Rinderle J; Neblett-Fanfair R; Oster AM; Smith DK
    Public Health Rep; 2022; 137(1):25-31. PubMed ID: 33646890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with HIV testing among people who inject drugs: a meta-analysis.
    Bayani A; Ghiasvand H; Rezaei O; Fattah Moghaddam L; Noroozi A; Ahounbar E; Higgs P; Armoon B
    J Addict Dis; 2020; 38(3):361-374. PubMed ID: 32552504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life-time HIV testing among people who inject drugs in Iran: results from the National Rapid Assessment and Response survey.
    Roshanfekr P; Karimi SE; Narouee S; Moftakhar L; Vameghi M; Ali D; Higgs P; Soleimanvandiazar N
    Front Public Health; 2023; 11():1253407. PubMed ID: 37915820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.